论文部分内容阅读
截至目前为止,用维生素C(Vc)治疗癌症的疗效报导很不一致,有的报导肿瘤完全消退,而有的则认为治疗无效,并有使用大剂量Vc的付作用。为了研究Vc的抗肿瘤作用,作者在予备实验中以2.52 mg苯并(a)芘加20mgVc皮下注射至雌性NMRI小鼠,肿瘤发病率从97%(单用苯并(a)芘)减少至30%。实验采用8周龄Wistar大鼠10只。将苯并(a)芘三辛酸甘油酯溶液1 ml[含10.08 mg的苯并(a)芘]作皮下注射,然后将动物分成两组。第一组的饮水中加入蔗糖2 g%,平均摄取溶液是21 ml/天/大鼠,相当于420 mg的糖。第二组的饮水中加入糖2g%及Vc 2.5
So far, the efficacy of vitamin C (Vc) in the treatment of cancer reported very inconsistent, some reported complete regression of the tumor, while others considered the treatment ineffective, and the use of high-dose Vc pay. In order to study the antitumor effect of Vc, the authors injected subcutaneously 2.52 mg of benzo (a) pyrene plus 20 mg of Vc into female NMRI mice in a preliminary experiment to reduce the incidence of tumors from 97% (benzo (a) pyrene alone) To 30%. Ten Wistar rats aged 8 weeks were used in the experiment. One ml of benzo [a] pyrenetrioctanoate solution [containing 10.08 mg of benzo [a] pyrene] was subcutaneously injected, and the animals were then divided into two groups. The first group of drinking water added sucrose 2 g%, the average ingestion solution is 21 ml / day / rat, equivalent to 420 mg of sugar. The second group of drinking water added 2g% of sugar and Vc 2.5